22.10.2021 • News

Air Liquide Advances French Green Hydrogen Project

Air Liquide has raised its stake in H2V Normandy from 40% to 100%, renaming it Air Liquide Normand’Hy. The French industrial gases group, which bought its original stake only in January, said the strategic investment will support the development of a low-carbon hydrogen ecosystem in the Normandy industrial basin. Financial details of the transaction were not disclosed.

François Jackow, executive vice president and a member of Air Liquide’s executive committee supervising Europe industries activities, commented: “This acquisition is a key milestone in producing renewable hydrogen on a large scale to supply industry and mobility markets. By 2030, Air Liquide is committed to bringing its total electrolysis capacity to 3 gigawatts.”

Air Liquide Normand’Hy plans to build a large-scale electrolyzer of at least 200 MW in the industrial zone of Port Jerome to produce renewable hydrogen. It will be connected to Air Liquide’s hydrogen pipeline network in Normandy.

The proton-exchange membrane (PEM) electrolzyer is expected to be commissioned in 2025, supplying 28,000 t/y of the gas for industrial and heavy mobility applications and avoiding the emission of more than 250,000 t/y of CO2.

In February, the Paris-based firm announced it had agreed to partner Siemens Energy to combine their expertise in PEM electrolysis technology.

Author: Elaine Burridge, Freelance Journalist

Air Liquide has raised its stake in H2V Normandy from 40% to 100%, renaming it...
Air Liquide has raised its stake in H2V Normandy from 40% to 100%, renaming it Air Liquide Normand’Hy. The company plans to build a large-scale electrolyzer of at least 200 megawatts in Port Jerome to produce 28,000 t/y renewable hydrogen with startup expected in 2025. (c) Air Liquide

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read